The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3

The mechanisms of how gain-of-function (GOF) mutant p53 drives carcinogenesis are unclear. Here, the authors show that a GOF mutant p53 requires its transactivation capability to induce mouse lung tumors and this is dependent on PLK3 phosphorylation of GOF mutant p53.

Guardado en:
Detalles Bibliográficos
Autores principales: Catherine A. Vaughan, Shilpa Singh, Mark A. Subler, Jolene J. Windle, Kazushi Inoue, Elizabeth A. Fry, Raghavendra Pillappa, Steven R. Grossman, Brad Windle, W. Andrew Yeudall, Swati Palit Deb, Sumitra Deb
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/54a056e3c31c4f638609e87d39e9e921
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:54a056e3c31c4f638609e87d39e9e921
record_format dspace
spelling oai:doaj.org-article:54a056e3c31c4f638609e87d39e9e9212021-12-02T13:57:31ZThe oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK310.1038/s41467-021-20928-82041-1723https://doaj.org/article/54a056e3c31c4f638609e87d39e9e9212021-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-20928-8https://doaj.org/toc/2041-1723The mechanisms of how gain-of-function (GOF) mutant p53 drives carcinogenesis are unclear. Here, the authors show that a GOF mutant p53 requires its transactivation capability to induce mouse lung tumors and this is dependent on PLK3 phosphorylation of GOF mutant p53.Catherine A. VaughanShilpa SinghMark A. SublerJolene J. WindleKazushi InoueElizabeth A. FryRaghavendra PillappaSteven R. GrossmanBrad WindleW. Andrew YeudallSwati Palit DebSumitra DebNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-19 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Catherine A. Vaughan
Shilpa Singh
Mark A. Subler
Jolene J. Windle
Kazushi Inoue
Elizabeth A. Fry
Raghavendra Pillappa
Steven R. Grossman
Brad Windle
W. Andrew Yeudall
Swati Palit Deb
Sumitra Deb
The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
description The mechanisms of how gain-of-function (GOF) mutant p53 drives carcinogenesis are unclear. Here, the authors show that a GOF mutant p53 requires its transactivation capability to induce mouse lung tumors and this is dependent on PLK3 phosphorylation of GOF mutant p53.
format article
author Catherine A. Vaughan
Shilpa Singh
Mark A. Subler
Jolene J. Windle
Kazushi Inoue
Elizabeth A. Fry
Raghavendra Pillappa
Steven R. Grossman
Brad Windle
W. Andrew Yeudall
Swati Palit Deb
Sumitra Deb
author_facet Catherine A. Vaughan
Shilpa Singh
Mark A. Subler
Jolene J. Windle
Kazushi Inoue
Elizabeth A. Fry
Raghavendra Pillappa
Steven R. Grossman
Brad Windle
W. Andrew Yeudall
Swati Palit Deb
Sumitra Deb
author_sort Catherine A. Vaughan
title The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
title_short The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
title_full The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
title_fullStr The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
title_full_unstemmed The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
title_sort oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of plk3
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/54a056e3c31c4f638609e87d39e9e921
work_keys_str_mv AT catherineavaughan theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT shilpasingh theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT markasubler theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT jolenejwindle theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT kazushiinoue theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT elizabethafry theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT raghavendrapillappa theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT stevenrgrossman theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT bradwindle theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT wandrewyeudall theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT swatipalitdeb theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT sumitradeb theoncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT catherineavaughan oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT shilpasingh oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT markasubler oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT jolenejwindle oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT kazushiinoue oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT elizabethafry oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT raghavendrapillappa oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT stevenrgrossman oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT bradwindle oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT wandrewyeudall oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT swatipalitdeb oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
AT sumitradeb oncogenicityoftumorderivedmutantp53isenhancedbytherecruitmentofplk3
_version_ 1718392321193541632